ultramicrosize griseofulvin

Generic: ultramicrosize griseofulvin

Labeler: chartwell rx, llc
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name ultramicrosize griseofulvin
Generic Name ultramicrosize griseofulvin
Labeler chartwell rx, llc
Dosage Form TABLET
Routes
ORAL
Active Ingredients

griseofulvin 165 mg/1

Manufacturer
Chartwell RX, LLC

Identifiers & Regulatory

Product NDC 62135-501
Product ID 62135-501_2e9858c1-8c99-8a0d-e063-6294a90a59a5
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA061996
Listing Expiration 2026-12-31
Marketing Start 1982-04-06

Pharmacologic Class

Established (EPC)
tubulin inhibiting agent [epc]
Physiologic Effect
decreased mitosis [pe] microtubule inhibition [pe]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 62135501
Hyphenated Format 62135-501

Supplemental Identifiers

RxCUI
245248
UPC
0362135501303
UNII
32HRV3E3D5
NUI
N0000008732 N0000175085 N0000175848

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name ultramicrosize griseofulvin (source: ndc)
Generic Name ultramicrosize griseofulvin (source: ndc)
Application Number ANDA061996 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 165 mg/1
source: ndc
Packaging
  • 30 TABLET in 1 BOTTLE (62135-501-30)
source: ndc

Packages (1)

62135-501-30 30 TABLET in 1 BOTTLE (62135-501-30)

Ingredients (1)

griseofulvin (165 mg/1)

Linked Drug Pages (1)

ULTRAMICROSIZE GRISEOFULVIN ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "2e9858c1-8c99-8a0d-e063-6294a90a59a5", "openfda": {"nui": ["N0000008732", "N0000175085", "N0000175848"], "upc": ["0362135501303"], "unii": ["32HRV3E3D5"], "rxcui": ["245248"], "spl_set_id": ["640c489e-f491-4805-a390-ef4be43e261b"], "pharm_class_pe": ["Decreased Mitosis [PE]", "Microtubule Inhibition [PE]"], "pharm_class_epc": ["Tubulin Inhibiting Agent [EPC]"], "manufacturer_name": ["Chartwell RX, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET in 1 BOTTLE (62135-501-30)", "package_ndc": "62135-501-30", "marketing_start_date": "20250130"}], "brand_name": "ULTRAMICROSIZE GRISEOFULVIN", "product_id": "62135-501_2e9858c1-8c99-8a0d-e063-6294a90a59a5", "dosage_form": "TABLET", "pharm_class": ["Decreased Mitosis [PE]", "Microtubule Inhibition [PE]", "Tubulin Inhibiting Agent [EPC]"], "product_ndc": "62135-501", "generic_name": "ULTRAMICROSIZE GRISEOFULVIN", "labeler_name": "Chartwell RX, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "ULTRAMICROSIZE GRISEOFULVIN", "active_ingredients": [{"name": "GRISEOFULVIN", "strength": "165 mg/1"}], "application_number": "ANDA061996", "marketing_category": "ANDA", "marketing_start_date": "19820406", "listing_expiration_date": "20261231"}